Wells Fargo’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$6 | – | 7297 |
|
|
2024
Q3 | $6 | Hold |
1
| – | – | ﹤0.01% | 6740 |
|
|
2024
Q2 | $10 | Sell |
1
-8
| -89% | -$71 | ﹤0.01% | 6634 |
|
|
2024
Q1 | $81 | Hold |
9
| – | – | ﹤0.01% | 6713 |
|
|
2023
Q4 | $48 | Hold |
9
| – | – | ﹤0.01% | 6940 |
|
|
2023
Q3 | $66 | Hold |
9
| – | – | ﹤0.01% | 6861 |
|
|
2023
Q2 | $70 | Hold |
9
| – | – | ﹤0.01% | 6958 |
|
|
2023
Q1 | $55 | Buy |
9
+1
| +13% | +$7 | ﹤0.01% | 7091 |
|
|
2022
Q4 | $61 | Hold |
8
| – | – | ﹤0.01% | 6946 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 7579 |
|
|
2022
Q2 | $0 | Buy |
8
+5
| +167% | +$44 | ﹤0.01% | 7693 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 8027 |
|
|
2021
Q4 | $0 | Sell |
3
-18
| -86% | -$967 | ﹤0.01% | 7980 |
|
|
2021
Q3 | $1K | Hold |
21
| – | – | ﹤0.01% | 6830 |
|
|
2021
Q2 | $2K | Buy |
21
+1
| +5% | +$87 | ﹤0.01% | 6574 |
|
|
2021
Q1 | $2K | Buy |
20
+18
| +900% | +$3.63K | ﹤0.01% | 6655 |
|
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 7160 |
|
|
2020
Q3 | $0 | Buy |
2
+1
| +100% | +$104 | ﹤0.01% | 7054 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6962 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$106 | ﹤0.01% | 6960 |
|
Wells Fargo's GHSI Position: Q4 2024 in Review
Wells Fargo sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 1 share — an estimated $6 sold.
Wells Fargo first reported a position in GHSI in Q1 2020 and held it in 19 quarters. The position peaked at $2K in Q2 2021. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.
- Wells Fargo reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 1 Guardion Health Sciences, Inc. Common Stock share in Q4 2024, an estimated $6.
- Wells Fargo first reported a position in Guardion Health Sciences, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
- Wells Fargo's Guardion Health Sciences, Inc. Common Stock position peaked at $2K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.